ctrl K

AI Score

Unlock

Barinthus Biotherapeutics (BRNS)

AI Score

Unlock

1.02

-0.03 (-2.86%)

At close: Mar 28, 2025, 11:01 AM

Barinthus Biotherapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	14.97M	802K	44.7M	268K	4.82M	6.87M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	-0.55
Gross Profit	14.97M	802K	44.7M	268K	4.82M	6.87M
Operating Income	-67.97M	-83.91M	-4.04M	-45.22M	-20.05M	-25.77M
Interest Income	2.68M	2.88M	3.1M	2K	267.06	40.37K
Pretax Income	-61.23M	-76.52M	850K	-51.14M	-17.84M	-22.79M
Net Income	-61.07M	-73.35M	5.34M	-50.87M	-17.71M	-20.82M
Selling & General & Admin	29.67M	39.84M	6.39M	25.12M	10.48M	2.33M
Research & Development	38.25M	41.41M	41.11M	16.37M	11.11M	29.97M
Other Expenses	15.02M	3.46M	567K	332K	42K	0.00
Operating Expenses	82.94M	84.72M	47.5M	41.49M	21.59M	32.3M
Interest Expense	53K	28K	19K	2.67M	3.6M	133.3K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.94M	84.72M	47.5M	41.49M	21.59M	32.64M
Income Tax	-153K	-3.17M	-4.47M	-28K	95K	-2.02M
Shares Outstanding (Basic)	39.35M	38.39M	37.25M	37.19M	47.65K	n/a
Shares Outstanding (Diluted)	39.35M	38.39M	38.17M	37.19M	47.65K	n/a
EPS (Basic)	-1.55	-1.91	0.14	-1.37	-371.62	n/a
EPS (Diluted)	-1.55	-1.91	0.14	-1.37	-371.62	n/a
EBITDA	-55.37M	-71.06M	6.4M	-47.86M	-14.14M	-22.31M
Depreciation & Amortization	5.8M	5.45M	5.54M	601.93K	210.02K	346.86K